授权盗U源码定制开发|【唯一TG:@heimifeng8】|盗U程序权限维持✨谷歌搜索留痕排名,史上最强SEO技术,20年谷歌SEO经验大佬✨Boots is star performer in WBA results, Future Renew launch makes big impact
Sandra Halliday Published
June 27, 2025
Walgreens Boots Alliance Q3 results on Tuesday showed growth in sales for the health & beauty retail giant, although profits growth proved tougher.
The company owns the American Walgreens chain and various international operations, particularly Boots in the UK — the dominant British beauty retailer that also has the UK license for Mothercare.
It said that for the entire group, Q3 sales rose 8.6% year on year to $35.4 billion, and rose 8.9% on a constant currency basis.
But health products and services demand was weaker. The company said “consumers continue to appreciate the value, convenience, and range of services provided by Walgreens and Boots. However, significantly lower demand for Covid-related services, a more cautious and value-driven consumer, and a recently weaker respiratory season created margin pressures in the quarter”.
Its operating loss was $0.5 billion, wider than $0.3 billion in the year-ago quarter, although that reflects a $431 million non-cash impairment of pharmacy license intangible assets in Boots UK.
Adjusted operating income was $1 billion, an increase of just 0.6% on a constant currency basis, reflecting improvements in US core pharmacy and International growth.
Net earnings in the third quarter were down to $118 million from $289 million but adjusted net earnings were $860 million, up 3.4%.
Boots, which has had its troubles in the recent past, was a star performer on the sales front. Boots UK sales rose 10.2% while its retail comparable sales growth was 13.4% on top of robust prior year growth of 24%.
It was helped by the launch of its world-first super peptide skincare range — Future Renew — under its No7 brand, with one product sold in the UK every two seconds on launch day and over 500,000 transactions in the first four weeks. It has launched in the US this month.
The company said US retail sales fell 1% and comparable sales fell 0.2%, although that wasn’t beauty-linked. In fact, beauty helped retail comp sales rise 0.2% with tobacco taken out of the mix.
With all that in mind, it’s no surprise that the business has revised its full-year adjusted earnings per share guidance down to $4-$4.05 from $4.45-$4.65, to reflect the quarter just gone “and a more cautious macroeconomic forward view”.
It added that it’s “taking immediate actions to drive sustainable growth in adjusted operating income in fiscal 2025”.